Φορτώνει......
The Effect of Hepatitis C Virologic Clearance on Cardiovascular Disease Biomarkers in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
BACKGROUND: Successful hepatitis C virus (HCV) treatment may reduce cardiovascular disease (CVD) risk and improve levels of CVD biomarkers produced outside the liver (nonhepatic biomarkers). METHODS: Stored serum or plasma from before and 24 weeks after end of HCV treatment (EOT) from human immuno...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Open Forum Infect Dis |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Oxford University Press
2014
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4324212/ https://ncbi.nlm.nih.gov/pubmed/25734172 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofu104 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|